NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE24124 Query DataSets for GSE24124
Status Public on Nov 04, 2010
Title The inferred mechanisms for prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system
Organism Homo sapiens
Experiment type Expression profiling by array
Third-party reanalysis
Summary Abstract

Aberrantly expressed signal transducer and activator of transcription 3 (STAT3) predicts poor prognosis primarily in estrogen receptor positive (ER(+)) breast cancers and activated STAT3 is overexpressed in luminal A subtype cells. The mechanisms contributing to the prognosis and/or subtype relevant features of *STAT3* in ER(+) breast cancers are* *through multiple interacting regulatory pathways including STAT3-MYC, STAT3-ER , STAT3-MYC-ER interactions and the direct action of activated STAT3. These results predict malignant events, treatment responses and a novel enhancer of tamoxifen resistance. The inferred crosstalk between ER and STAT3 in regulating their shared target gene-*METAP2* is partially validated in the luminal B breast cancer cell line-MCF7. Taken together, we identify a poor prognosis relevant gene set within the *STAT3* network and a robust one in a subset of patients. *VEGFA*, *ABL1*, *LYN*, *IGF2R* and* STAT3* are suggested therapeutic targets for further study based upon the degree of differential expression in our model.

Keywords: STAT3 transcriptional regulatory network, prognosis, tamoxifen resistance, tumorigenesis, breast cancer.
 
Overall design 181 surgical specimens of primary infiltrating ductal carcinoma (IDC) were obtained from patients who underwent surgery at National Taiwan University Hospital (NTUH) between 1998 and 2007. They include 90 ER(+) IDCs and 91 ER(-) IDCs. Tissue samples were excised, snap frozen in liquid nitrogen, and stored at -80℃. Breast cancer samples containing relatively pure cancer as defined by greater than 50% tumor cells per high-power field examined in an adjacent section of tumor sample were for this study (Lien HC, et al. Oncogene 2007; 26: 7859-71). Twenty five non-tumor samples were surgically taken from breast cancer patients in 181 IDC patients to generate 25 gene expression profiles as a control in this study. All patients had given informed consent according to the guidelines approved by the Institutional Review Board at NTUH.

The matrix file linked to the bottom of this Series includes reanalyzed data from the 119 Samples of this Series and 87 Samples from Series GSE9309 and GSE17040.
 
Contributor(s) Liu LD, Chang L, Kuo W, Hwa H, Lin Y, Jeng M, Roth DA, Chang K, Hsieh F
Citation(s) 26366408, 23516564, 22553415
Submission date Sep 14, 2010
Last update date Feb 21, 2020
Contact name Fon-Jou Hsieh
E-mail(s) fjhsieh@ntu.edu.tw
Organization name National Taiwan University
Department Department of obstetrics and gynecology
Street address No. 7, Chung-Shan South Rd
City Taipei
ZIP/Postal code 100
Country Taiwan
 
Platforms (1)
GPL887 Agilent-012097 Human 1A Microarray (V2) G4110B (Feature Number version)
Samples (119)
GSM593690 breast nontumor part_N_rep1 5293
GSM593691 breast nontumor part_N_rep1 5403
GSM593692 breast nontumor part_N_rep1 5405
Relations
Reanalysis of GSM237162
Reanalysis of GSM237163
Reanalysis of GSM237164
Reanalysis of GSM237171
Reanalysis of GSM237172
Reanalysis of GSM237137
Reanalysis of GSM237139
Reanalysis of GSM237140
Reanalysis of GSM237141
Reanalysis of GSM237143
Reanalysis of GSM237144
Reanalysis of GSM237147
Reanalysis of GSM237148
Reanalysis of GSM237149
Reanalysis of GSM237150
Reanalysis of GSM237151
Reanalysis of GSM237152
Reanalysis of GSM237153
Reanalysis of GSM237154
Reanalysis of GSM237155
Reanalysis of GSM237156
Reanalysis of GSM237157
Reanalysis of GSM237158
Reanalysis of GSM237159
Reanalysis of GSM237165
Reanalysis of GSM237166
Reanalysis of GSM237167
Reanalysis of GSM237168
Reanalysis of GSM237170
Reanalysis of GSM237174
Reanalysis of GSM237175
Reanalysis of GSM237176
Reanalysis of GSM237177
Reanalysis of GSM237178
Reanalysis of GSM237179
Reanalysis of GSM237180
Reanalysis of GSM237181
Reanalysis of GSM237182
Reanalysis of GSM237183
Reanalysis of GSM237184
Reanalysis of GSM237185
Reanalysis of GSM237186
Reanalysis of GSM237187
Reanalysis of GSM237188
Reanalysis of GSM237190
Reanalysis of GSM237191
Reanalysis of GSM237193
Reanalysis of GSM237194
Reanalysis of GSM237195
Reanalysis of GSM237197
Reanalysis of GSM237198
Reanalysis of GSM237199
Reanalysis of GSM237200
Reanalysis of GSM237202
Reanalysis of GSM237203
Reanalysis of GSM237244
Reanalysis of GSM237245
Reanalysis of GSM237246
Reanalysis of GSM237248
Reanalysis of GSM237249
Reanalysis of GSM237250
Reanalysis of GSM237251
Reanalysis of GSM237252
Reanalysis of GSM237253
Reanalysis of GSM237254
Reanalysis of GSM237255
Reanalysis of GSM237256
Reanalysis of GSM237257
Reanalysis of GSM237259
Reanalysis of GSM237260
Reanalysis of GSM237261
Reanalysis of GSM237263
Reanalysis of GSM237264
Reanalysis of GSM237266
Reanalysis of GSM237267
Reanalysis of GSM237268
Reanalysis of GSM237270
Reanalysis of GSM237271
Reanalysis of GSM237272
Reanalysis of GSM237273
Reanalysis of GSM237274
Reanalysis of GSM237275
Reanalysis of GSM237276
Reanalysis of GSM237277
Reanalysis of GSM237278
Reanalysis of GSM426480
Reanalysis of GSM426481
BioProject PRJNA130065

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE24124_RAW.tar 526.9 Mb (http)(custom) TAR (of TXT)
GSE24124_reanalysis.txt.gz 21.1 Mb (ftp)(http) TXT
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap